Timothy Schulz-Utermoehl
TS
Timothy Schulz-Utermoehl
Head of DMPK
Rate
About
Timothy Schulz-Utermoehl has over 20 years of DMPK experience across academic, pharmaceutical, biotech, and CRO sectors, spanning early- and late-stage discovery research and preclinical development. He has held various roles of increasing responsibility, including ADME Section Head at AstraZeneca and Director, Head of DMPK at Sygnature Discovery. He is currently the Head of DMPK at Lario Therapeutics.
Frequently asked
Who is Timothy Schulz-Utermoehl?
Timothy Schulz-Utermoehl has over 20 years of DMPK experience across academic, pharmaceutical, biotech, and CRO sectors, spanning early- and late-stage discovery research and preclinical development. He has held various roles of increasing responsibility, including ADME Section Head at AstraZeneca and Director, Head of DMPK at Sygnature Discovery. He is currently the Head of DMPK at Lario Therapeu…
What is Timothy Schulz-Utermoehl's current role?
Timothy Schulz-Utermoehl is currently Head of DMPK.
Comments
No comments yet. Be the first to share your take.
Profile
About Timothy Schulz-Utermoehl
Timothy Schulz-Utermoehl is Head of DMPK. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.